APA (7th ed.) Citation

Gion, M., Llombart Cussac, A., Perez Garcia, J., Blancas López-Barajas, I., Rea, A., Fazal Salom, J., . . . Hurvitz, S. (2025). 460eTiP TELESCOPE: Neoadjuvant phase II study of pembrolizumab, carboplatin, and paclitaxel for stage I triple-negative breast cancer. Annals of Oncology, 36, S390. https://doi.org/10.1016/j.annonc.2025.08.883

Chicago Style (17th ed.) Citation

Gion, M., et al. "460eTiP TELESCOPE: Neoadjuvant Phase II Study of Pembrolizumab, Carboplatin, and Paclitaxel for Stage I Triple-negative Breast Cancer." Annals of Oncology 36 (2025): S390. https://doi.org/10.1016/j.annonc.2025.08.883.

MLA (9th ed.) Citation

Gion, M., et al. "460eTiP TELESCOPE: Neoadjuvant Phase II Study of Pembrolizumab, Carboplatin, and Paclitaxel for Stage I Triple-negative Breast Cancer." Annals of Oncology, vol. 36, 2025, p. S390, https://doi.org/10.1016/j.annonc.2025.08.883.